Simcere Pharmaceutical Group names Yushan Wan as acting CFO

Simcere Pharmaceutical Group, a pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, has appointed Yushan Wan, Simcere's corporate controller, as acting chief financial officer as of the effective date.

 

Wan replaces Frank Zhao.

 

Wan joined Simcere in 2000 and has been serving as the Company's corporate controller since 2007. Wan has a bachelor's degree in biochemistry and a master's degree in accounting from Nanjing University and is a Chinese Certified Public Accountant.
 

Suggested Articles

Some of you might have already been aware of the news that Questex—with the aim to focus on event business—will shut down permanently all media brands in Asia…

Some advice for transitioning into an advisory role

Global risks are intensifying but the collective will to tackle them appears to be lacking. Check out this report for areas of concern